OLR1 and hepatocellular carcinoma: LOX-1+CD15+ PMN-MDSCs from HCC patients suppressed antigen non-specific T cells proliferation and IFNγ production, which can be reversed by ROS inhibitor NAC, ARG1 inhibitor, and L-arginine [21].